JW Pharmaceutical Corp Cash Flow Quality Index
JW Pharmaceutical Corp cash flow quality index. JW Pharmaceutical Corp (001065) has a Cash Flow Quality Index of 1.52x as of June 2026. Operating cash flow of ₩42.51 Billion exceeds net income of ₩27.89 Billion, indicating high earnings quality where cash backs reported profits. See 001065 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of JW Pharmaceutical Corp (2015–2025)
Cash flow quality index of JW Pharmaceutical Corp from 2015 to 2025. Historical Cash Flow Quality Index for JW Pharmaceutical Corp across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore 001065 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
JW Pharmaceutical Corp Cash Flow Quality Index by Year (2015–2025)
JW Pharmaceutical Corp cash flow quality index by year from 2015 to 2025. Year-by-year earnings quality comparison for JW Pharmaceutical Corp. For the full cash flow conversion analysis, see cash flow conversion of JW Pharmaceutical Corp.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.57x | ₩96.40 Billion | ₩61.51 Billion | ▲ +28.4% |
| 2024 | 1.22x | ₩79.39 Billion | ₩65.04 Billion | ▼ -51.2% |
| 2023 | 2.50x | ₩87.16 Billion | ₩34.84 Billion | ▲ +47.8% |
| 2022 | 1.69x | ₩56.76 Billion | ₩33.55 Billion | ▼ -73.8% |
| 2018 | 6.47x | ₩52.11 Billion | ₩8.06 Billion | ▲ +403.9% |
| 2015 | -2.13x | ₩-4.17 Billion | ₩1.96 Billion | — |